Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on August 12, 2022 has approved the unaudited financial results for the quarter ended June 30, 2022 (Standalone and Consolidated) as enclosed. It enclosed the Limited Review Report dated August 12, 2022 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, Deloitte Haskins & Sells LLP. The Board meeting commenced at 11.15 am and concluded at 11.50 am.
The above information is a part of company’s filings submitted to BSE.
